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Background: Acute myocardial infarction (AMI) triggers mobilization of bone marrow (BM)-derived stem cells (BMSCs) through poorly understood 
processes. We sought to define the role of bioactive lipids, such as sphingosine-1 phosphate (S1P) in the mobilization of BMSCs during AMI.
Methods: Peripheral blood samples from matched controls and patients presenting with ST-elevation myocardial infarction (STEMI) were examined.
Results: Plasma S1P levels were highest within 6 hours of AMI presentation 1.5 ± 0.15 microM and declined to 0.96 ± 0.15 microM at 48 hours 
(P < 0.05 for 6 hours vs. controls) (Fig. 1A). This was paralleled by early significant increase in circulating lineage negative (Lin-)/CD45-/CD34+, 
CD133+ and CXCR4+ BMSCs (P < 0.01 vs. controls) (Fig. 1B-D). Plasma obtained from STEMI patients in the early phases following STEMI stimulated 
the migration of human BM-derived Lin-/CXCR4+ and Lin-/CD34+ BMSCs in chemotaxis assays (7-8-fold increase vs. vehicle, P < 0.05), this effect 
was blunted by charcoal stripping of the plasma (CSP) and was further inhibited by the specific S1P1 receptor antagonists W146 (10 microM) and 
VPC20139 (10 microM) (Fig. 1E and F).
Conclusion: This is the first human study to suggest that elevated S1P and C1P levels early in the course of AMI may modulate BMSCs 
mobilization. Future studies examining the therapeutic manipulation of S1P and its receptors for myocardial regeneration are warranted.
 
